Exhibitor

Imbio is turning standard medical imaging into AI-powered personalized insights for patients with chronic lung conditions. Imbio’s fully-automated, regulatory cleared, quantitative analysis includes Lung Density Analysis for assisting COPD diagnosis, and Lung Texture Analysis for quantifying and visualizing the radiological textures key to identifying ILD’s and other fibrotic conditions. (www.imbio.com)